rs17855561
Positions:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_005046.4(KLK7):c.678C>T(p.Cys226=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000249 in 1,613,418 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00020 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 4 hom. )
Consequence
KLK7
NM_005046.4 synonymous
NM_005046.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.70
Genes affected
KLK7 (HGNC:6368): (kallikrein related peptidase 7) This gene encodes a member of the kallikrein subfamily of serine proteases. These enzymes have diverse physiological functions and many kallikrein genes are biomarkers for cancer. The encoded protein has chymotrypsin-like activity and plays a role in the proteolysis of intercellular cohesive structures that precedes desquamation, the shedding of the outermost layer of the epidermis. The encoded protein may play a role in cancer invasion and metastasis, and increased expression of this gene is associated with unfavorable prognosis and progression of several types of cancer. Polymorphisms in this gene may play a role in the development of atopic dermatitis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, which is one of fifteen kallikrein subfamily members located in a gene cluster on chromosome 19. [provided by RefSeq, May 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 19-50977620-G-A is Benign according to our data. Variant chr19-50977620-G-A is described in ClinVar as [Benign]. Clinvar id is 784839.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.7 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLK7 | NM_005046.4 | c.678C>T | p.Cys226= | synonymous_variant | 6/6 | ENST00000595820.6 | NP_005037.1 | |
KLK7 | NM_139277.2 | c.678C>T | p.Cys226= | synonymous_variant | 6/6 | NP_644806.1 | ||
KLK7 | NM_001243126.1 | c.657C>T | p.Cys219= | synonymous_variant | 5/5 | NP_001230055.1 | ||
KLK7 | NM_001207053.2 | c.462C>T | p.Cys154= | synonymous_variant | 5/5 | NP_001193982.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLK7 | ENST00000595820.6 | c.678C>T | p.Cys226= | synonymous_variant | 6/6 | 1 | NM_005046.4 | ENSP00000470538 | P1 | |
ENST00000594512.1 | n.297+4287G>A | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 151860Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
31
AN:
151860
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00121 AC: 305AN: 251352Hom.: 4 AF XY: 0.000787 AC XY: 107AN XY: 135880
GnomAD3 exomes
AF:
AC:
305
AN:
251352
Hom.:
AF XY:
AC XY:
107
AN XY:
135880
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000253 AC: 370AN: 1461558Hom.: 4 Cov.: 32 AF XY: 0.000204 AC XY: 148AN XY: 727050
GnomAD4 exome
AF:
AC:
370
AN:
1461558
Hom.:
Cov.:
32
AF XY:
AC XY:
148
AN XY:
727050
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000204 AC: 31AN: 151860Hom.: 1 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74160
GnomAD4 genome
AF:
AC:
31
AN:
151860
Hom.:
Cov.:
32
AF XY:
AC XY:
19
AN XY:
74160
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at